PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
22,129,138
Share change
-1,260,710
Total reported value
$3,891,065
Price per share
$0.18
Number of holders
26
Value change
-$785,163
Number of buys
4
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q3 2022

As of 30 Sep 2022, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,129,138 shares. The largest 10 holders included NEA Management Company, LLC, Avidity Partners Management LP, Rock Springs Capital Management LP, MAI Capital Management, VANGUARD GROUP INC, JOHNSON & JOHNSON, BlackRock Inc., DAFNA Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, and Platform Technology Partners. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.